Cargando…

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

BACKGROUND: The INNODIA consortium has established a pan-European infrastructure using validated centres to prospectively evaluate clinical data from individuals with newly diagnosed type 1 diabetes combined with centralised collection of clinical samples to determine rates of decline in beta-cell f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunger, David B., Bruggraber, Sylvaine F. A., Mander, Adrian P., Marcovecchio, M. Loredana, Tree, Timothy, Chmura, Piotr Jaroslaw, Knip, Mikael, Schulte, Anke M., Mathieu, Chantal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116021/ https://www.ncbi.nlm.nih.gov/pubmed/35585600 http://dx.doi.org/10.1186/s13063-022-06259-z

Ejemplares similares

Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory
por: Moulder, Robert, et al.
Publicado: (2023)

Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes
por: Wilhelm-Benartzi, Charlotte S, et al.
Publicado: (2021)

Introduction to the Polish branch of the INNODIA program
por: Pokrywka, Paulina, et al.
Publicado: (2023)

Gene expression signature predicts rate of type 1 diabetes progression
por: Suomi, Tomi, et al.
Publicado: (2023)

Extended Family History of Type 1 Diabetes and Phenotype and Genotype of Newly Diagnosed Children
por: Parkkola, Anna, et al.
Publicado: (2013)

Family history of type 2 diabetes and characteristics of children with newly diagnosed type 1 diabetes
por: Parkkola, Anna, et al.
Publicado: (2020)

A1C Variability as an Independent Risk Factor for Microalbuminuria in Young People With Type 1 Diabetes
por: Marcovecchio, M. Loredana, et al.
Publicado: (2011)

Frequent Monitoring of C-Peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at Home
por: Willemsen, Ruben H, et al.
Publicado: (2018)

FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children
por: Viisanen, Tyyne, et al.
Publicado: (2019)

Insulin Administration and Rate of Glucose Appearance in People With Type 1 Diabetes
por: Pennant, Mary E., et al.
Publicado: (2008)

Research and young paediatricians
por: Marcovecchio, M Loredana
Publicado: (2014)

Newly Diagnosed Hypokalemic Periodic Paralysis Triggered by COVID-19
por: Schulte, Kelly, et al.
Publicado: (2023)

The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension
por: Pawlak-Chomicka, Regina, et al.
Publicado: (2022)

The molecular mechanisms underlying diabetic complications
por: Chiarelli, Francesco, et al.
Publicado: (2013)

DKA management and outcomes
por: Chiarelli, Francesco, et al.
Publicado: (2013)

Preventing Cardiovascular Complications in Type 1 Diabetes: The Need for a Lifetime Approach
por: Chiesa, Scott T., et al.
Publicado: (2021)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Nutritional Status of Children with Newly Diagnosed Food Allergies
por: Jasielska, Martyna, et al.
Publicado: (2023)

Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial
por: Marcovecchio, M. Loredana, et al.
Publicado: (2020)

S203: QUADRUPLET INDUCTION THERAPY, ASCT AND MRD-MODULATED CONSOLIDATION AND TREATMENT CESSATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF THE MASTER TRIAL
por: Costa, Luciano, et al.
Publicado: (2023)

Biomarkers of diabetic kidney disease
por: Colhoun, Helen M., et al.
Publicado: (2018)

Interstitial photodynamic therapy for newly diagnosed glioblastoma
por: Quach, Stefanie, et al.
Publicado: (2023)

Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)

Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study
por: Vencio, Sérgio, et al.
Publicado: (2021)

Diet, Gut, and Type 1 Diabetes: Role of Wheat-Derived Peptides?
por: Knip, Mikael
Publicado: (2009)

Pharmaceutical/food grade titanium dioxide particles are absorbed into the bloodstream of human volunteers
por: Pele, Laetitia C., et al.
Publicado: (2015)

Characterisation of zinc delivery from a nipple shield delivery system using a breastfeeding simulation apparatus
por: Scheuerle, Rebekah L., et al.
Publicado: (2017)

Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015)

A Review of Newly Diagnosed Glioblastoma
por: Oronsky, Bryan, et al.
Publicado: (2021)

Newly Diagnosed Glioblastoma in Elderly Patients
por: Yuen, Carlen A., et al.
Publicado: (2022)

Maternal but Not Paternal Association of Ambulatory Blood Pressure With Albumin Excretion in Young Offspring With Type 1 Diabetes
por: Marcovecchio, M. Loredana, et al.
Publicado: (2010)

Update on statural growth and pubertal development in obese children
por: Leonibus, Chiara De, et al.
Publicado: (2012)

Doravirine/lamivudine/tenofovir disoproxil fumarate-induced hypertriglyceridemia in a newly diagnosed AIDS patient
por: Barchi, Virginia, et al.
Publicado: (2022)

Insulin Resistance Is Associated with an Unfavorable Serum Lipoprotein Lipid Profile in Women with Newly Diagnosed Gestational Diabetes
por: Huhtala, Mikael, et al.
Publicado: (2023)

New developments for ALICE MasterClasses and the new Particle Therapy MasterClass
por: Graczykowski, Lukasz Kamil, et al.
Publicado: (2019)

New developments for ALICE MasterClasses and the new Particle Therapy MasterClass
por: Graczykowski, Lukasz Kamil, et al.
Publicado: (2020)

Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes
por: Matthews, David, et al.
Publicado: (2020)

Mastering the Master Space
por: Forcella, Davide, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_2j2e104n1sci4n251ev0egjs66